Table 2 An overview of the specifications of the evaluated commercial kits and protocols.
Ā | QuickRNA microprep | RNeasy micro | TRIzol reagent | TRIzolā+āRNeasy micro | TRIzolā+āPureLink RNA mini | Aurum total RNA mini |
---|---|---|---|---|---|---|
Starting material | \(\le\) 10Ā mg tissue (stored at -80ĀŗC) | ā<ā5Ā mg tissue (stored at -80ĀŗC) | 50ā100Ā mg tissue (stored at -80ĀŗC) | ā<ā15Ā mg tissue (stored at āĀ 80 °C) | \(\le\) 200Ā mg tissue (stored at āĀ 80 °C) | \(\le\) 40Ā mg thawed tissue (stored at -80ĀŗC) |
Approx. preparation time | ā~ā20ā30Ā min | ā~ā30ā40Ā min | ā~ā1ā2Ā h | ā~ā1ā2Ā h | ā~ā60Ā min | ā~ā30ā60Ā min |
Binding capacity | 10 µg total RNA | 100 µg total RNA | N/A | 100 µg total RNA | 1000 µg total RNA | ā>ā100 µg total RNA |
Storage | RT | RT | 15ā30 °C | 15ā30 °C/RT | 15ā30 °C/RT | RT |
DNase digestion | Yes | Yes | No | No | No | Yes |
Elution volume | 20 µl | 10ā14 µl | N/A | 20 µl | 30 µl | 30 µl-2 \(\times\) 40 µl |
Advantages | Rapid procedure | Rapid procedure | High RNA yield | High RNA yield | Reduced contamination | Purityā>ā1.96 |
Disadvantages | Inconsistent recovery | Inconsistent recovery | Low purity | Low purity | Low purity | Purityā>ā2.2 |
Low RNA yield | Low RNA yield | Phenol contamination | Phenol contamination | Phenol contamination | Low RNA yield |